首页|麝香保心丸辅助治疗对冠心病患者的疗效研究

麝香保心丸辅助治疗对冠心病患者的疗效研究

扫码查看
目的:研究麝香保心丸辅助治疗冠心病患者,观察对心绞痛的影响效果.方法:选取2020年 3 月至2022年3 月本院收治的冠心病心绞痛患者 88 例作为研究对象,随机分为观察组(n=45)和对照组(n=43).对照组给予曲美他嗪等治疗,观察组在对照组治疗基础上加用麝香保心丸.疗程3 m后,比较两组患者的临床疗效,采用多普勒彩超检测仪检测治疗前后心功能指标(左心室射血分数(Left ventricular ejection fraction,LVEF)、左心室舒张末期内径(Left ventricular end-diastolic dimension,LVEDD)、(Left ventricular end-systolic dimension,LVESD)),采用酶联免疫吸附法测定治疗前后血管内皮功能指标(内皮素(Endothelin-1,ET-1)、一氧化氮(Nitrogen oxide,NO))及炎症因子水平(白介素-6(Interleukin-6,IL-6)、肿瘤坏死因子α(tumor necrosis factor-α,TNF-α)、超敏C-反应蛋白(High sensitive C-reactive protein,hs-CRP)),观察治疗期间的不良反应.结果:观察组治疗有效率为93.33%高于对照组的 74.42%(P<0.05);治疗后,观察组LVEF高于对照组,LVEDD及LVESD低于对照组(P<0.05);观察组ET-1低于对照组,NO高于对照组(P<0.05);观察组IL-6、TNF-α及hs-CRP低于对照组(P<0.05);两组的不良反应发生率比较,差异无统计学意义(P>0.05).结论:麝香保心丸辅助治疗冠心病心绞痛的疗效确切,心功能及血管内皮功能明显改善,炎症反应减弱,且不良反应少.
Curative effect of Shexiang Baoxin Pill on coronary heart disease
Objective:To study the curative effect of Shexiang Baoxin Pill on angina pectoris in patients with coronary heart disease.Methods:A total of 88 patients with angina pectoris of coronary heart disease admitted to the hospital were enrolled as the research objects between March 2020 and March 2022.They were randomly divided into observation group(n=45)and control group(n=43).The control group was treated with trimetazidine,while observation group was additionally treated with Shexiang Baoxin Pills.After 3 months of treatment,clinical curative effect was compared between the two groups.The cardiac function indexes(left ventricular ejection fraction(LVEF),left ventricular end-diastolic dimension(LVEDD),left ventricular end-systolic dimension(LVESD))were detected by color Doppler ultrasound detector before and after treatment.The levels of vascular endothelial function indexes(endothelin-1(ET-1),nitrogen oxide(NO))and inflammatory factors(interleukin-6(IL-6),tumor necrosis factor-α(TNF-α),high sensitive C-reactive protein(hs-CRP))were detected by enzyme-linked immunosorbent assay before and after treatment.The adverse reactions during treatment were observed.Results:The response rate of treatment in observation group was higher than that in control group(93.33%vs 74.42%,P<0.05).After treatment,LVEF in observation group was higher than that in control group,while LVEDD and LVESD were lower than those in control group(P<0.05).ET-1 in observation group was lower than that in control group,while NO was higher than that in control group(P<0.05).The levels of IL-6,TNF-α and hs-CRP in observation group were lower than those in control group(P<0.05).There was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusion:Curative effect of Shexiang Baoxin Pill is significant on angina pectoris of coronary heart disease,which can significantly improve cardiac function and vascular endothelial function,and relieve inflammatory response,and less adverse reactions.

Shexiang Baoxin PillCoronary heart diseaseAngina pectorisCardiac function

曹利利

展开 >

新郑市公立人民医院心内科,河南 郑州 451100

麝香保心丸 冠心病 心绞痛 心功能

2024

四川生理科学杂志
四川省生理科学会

四川生理科学杂志

影响因子:0.575
ISSN:1671-3885
年,卷(期):2024.46(1)
  • 12